Alzheimer’s Drug Coverage Issues Move To Forefront With Biogen’s Plan To Seek Approval

 
• By Cathy Kelly
  
Alzheimers_Father_Son
The Value Of Alzheimer's Drugs Would Include Benefits Outside The Health Care System.
Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

SpotifyApple PodcastsWebsite

More from Market Access

More from Pink Sheet